<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Samples of peripheral blood were taken from 11 patients (blood group A, B and O), suffering from <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), before and after chemotherapy, compared to <z:mpath ids='MPATH_458'>normal</z:mpath> control samples </plain></SENT>
<SENT sid="1" pm="."><plain>The RBC's typing was done by standard agglutination technique (with conventional human and murine anti-sera) and flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>While using different reagent dilutions, a lower expression of the A or B antigen was noticed in <z:hpo ids='HP_0000001'>all</z:hpo> patients, even if direct typing of the RBC's revealed an apparently <z:mpath ids='MPATH_458'>normal</z:mpath> pattern </plain></SENT>
<SENT sid="3" pm="."><plain>The most important <z:mpath ids='MPATH_63'>depletion</z:mpath> of antigenic expression was found to correspond to the highest concentration of myeloblasts in the bone marrow, with hypoplastic erythrocytic series </plain></SENT>
<SENT sid="4" pm="."><plain>The modified H reactivity, detected at admission, was still present after complete remission, as an expression of the <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Studies of the H expression could eventually become a parameter of evaluating the moment of relapse of the <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath> </plain></SENT>
</text></document>